Reports for BAUSCH HEALTH, CANADA INC.
Company Name
BAUSCH HEALTH, CANADA INC.
Totals |
||
Shortage reports |
346 |
|
| Actual shortage: | 11 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 34 (10%) | |
| Resolved: | 301 (87%) | |
Discontinuation Reports |
13 |
|
| To be discontinued: | 1 (8%) | |
| Discontinued: | 12 (92%) | |
| Reversed: | 0 (0%) | |
Late reports |
96 (27%) |
|
Overdue reports |
1 (8%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MESTINON | 60MG | TABLET | Resolved | 2019-06-21 | 2019-07-24 | 87189 |
| MESTINON | 60MG | TABLET | Resolved | 2024-03-20 | 2024-03-28 | 222851 |
| MESTINON-SR | 180MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-04-06 | 2018-04-13 | 45130 |
| RETIN-A | 0.05% | CREAM | Resolved | 2017-08-17 | 2018-03-30 | 19739 |
| RETIN-A | 0.05% | CREAM | Resolved | 2021-04-21 | 2021-05-19 | 137879 |
| RETIN-A | 0.05% | CREAM | Resolved | 2023-11-23 | 2024-02-01 | 211258 |
| RETIN-A | 0.025% | GEL | Resolved | 2018-04-06 | 2018-06-20 | 45139 |
| RETIN-A | 0.025% | GEL | Resolved | 2019-03-22 | 2019-09-10 | 79311 |
| RETIN-A | 0.025% | GEL | Resolved | 2021-08-26 | 2021-11-10 | 144618 |
| RETIN-A | 0.025% | GEL | Resolved | 2022-09-23 | 2022-09-28 | 170140 |
| RETIN-A | 0.025% | GEL | Resolved | 2023-11-23 | 2024-01-22 | 211261 |
| RETIN-A | 0.025% | GEL | Resolved | 2024-02-22 | 2024-04-03 | 220170 |
| DELATESTRYL | 200MG | SOLUTION | Resolved | 2017-06-16 | 2017-06-24 | 12960 |
| DELATESTRYL | 200MG | SOLUTION | Resolved | 2017-09-25 | 2018-01-23 | 23236 |
| DELATESTRYL | 200MG | SOLUTION | Resolved | 2018-11-09 | 2019-01-11 | 66583 |
| DELATESTRYL | 200MG | SOLUTION | Resolved | 2019-11-13 | 2020-01-09 | 98649 |
| DELATESTRYL | 200MG | SOLUTION | Resolved | 2020-05-28 | 2020-09-30 | 116048 |
| DELATESTRYL | 200MG | SOLUTION | Resolved | 2021-02-26 | 2021-09-13 | 134792 |
| DELATESTRYL | 200MG | SOLUTION | Resolved | 2022-12-02 | 2022-12-21 | 176956 |
| DELATESTRYL | 200MG | SOLUTION | Resolved | 2023-01-18 | 2023-04-22 | 181436 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VITAMIN A ACID | 0.01% | GEL | To be discontinued | 2024-01-30 | 2024-01-30 | 217835 |
| VITAMIN A ACID | 0.05% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217843 |
| DELATESTRYL | 200MG | SOLUTION | Discontinued | 2024-03-11 | 2024-04-26 | 221772 |
| VITAMIN A ACID | 0.025% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217848 |
| THEOLAIR | 80MG | SOLUTION | Discontinued | 2021-04-26 | 2021-04-27 | 138081 |
| LIDEX | 0.05% | CREAM | Discontinued | 2023-12-08 | 2023-12-08 | 212804 |
| AIROMIR | 100MCG | METERED-DOSE AEROSOL | Discontinued | 2023-11-29 | 2023-11-29 | 211859 |
| ALTACE HCT | 12.5MG 2.5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214011 |
| ALTACE HCT | 12.5MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214014 |
| ALTACE HCT | 12.5MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214024 |
| ALTACE HCT | 25MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214017 |
| ALTACE HCT | 25MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214027 |
| LODALIS | 3.75G | POWDER FOR SUSPENSION | Discontinued | 2023-12-08 | 2024-02-20 | 212799 |
Showing 1 to 13 of 13